Skip to content

Using Artificial Intelligence for the Detection of Respiratory Diseases Associated With Pollution

Using Artificial Intelligence for the Detection of Respiratory Diseases Associated With Pollution

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06512142
Acronym
SmartLungs
Enrollment
30000
Registered
2024-07-22
Start date
2023-11-01
Completion date
2025-03-31
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Asthma, Emphysema, Lung Neoplasm

Keywords

complex networks, lung imaging, spectral analysis, geolocation

Brief summary

Generating a picture at the city level, through geospatial and temporal grouping a lung diseases associated or exacerbated by pollution (COPD, AB and neoplasm pulmonary or pleural) and correlating this data with pollution data. Development of an accurate and prognostic HRCT imaging diagnostic tool, computer assisted in the mentioned pathology, by generating an algorithm capable of to detect early the follow-up tomographic imaging lesions, as well as to evaluate objective their speed of evolution. Validation of the proposed algorithm by comparison with medical diagnosis.

Interventions

None listed

Sponsors

University of Medicine and Pharmacy Victor Babes Timisoara
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must be diagnosed with COPD and/or asthma and/or pulmonary neoplasm and/or secondary pulmonary, pleural or mediastinal determinations, suspected or confirmed, according to ICD-10. * Patients will be included regardless of the type of hospitalization, continuous or day. * The existence of freely expressed consent, carried out according to Ethics standards professional (from the observation sheet). For stage 2 * The use of HRCT images, in DICOM format, with a maximum cup thickness of 1.5 mm and with an average of 250 cups; no image acquisition errors; * Imaging monitoring at a time interval;. * Respiratory function evaluation data available: spirometry +/- the factor of gaseous diffusion (DLco);

Exclusion criteria

For both stages: \- Patients who do not have a stable real domicile (eg social cases) or are not from the Timis county For stage 2 * Patients who do not have HRCT images available or cannot be followed. * Patients who have insufficient quality HRCT images. * Patients who have a history of lung surgery. * Patients who have a history of allergies to contrast agents used in imaging HRCT.

Design outcomes

Primary

MeasureTime frameDescription
Correlation between lung diseases and pollutionDecember 2023 - December 2024Establishing the relationship between the incidence and exacerbation of lung diseases (COPD, acute bronchitis, and pulmonary or pleural neoplasms) and pollution levels through geospatial and temporal analysis at the city /county level
Development of a diagnostic algorithmSeptember 2024 - March 2024Creating an accurate, computer-assisted HRCT imaging diagnostic tool designed to detect early tomographic lesions and evaluate the progression speed of these lesions in patients with the mentioned pathologies.

Countries

Romania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026